Lakefront Biotherapeutics American Depositary Shares (LKFT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for LKFT. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 77 institutions reported holding LKFT, with 32.1 million shares worth $960.3 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Gilead Sciences | 16,707,477 | $500M | UNCHANGED |
| Tang Capital Management | 3,785,991 | $114M | UNCHANGED |
| Madison Avenue Partners | 3,447,807 | $103M | INCREASED |
| Prosight Management | 2,043,344 | $61M | INCREASED |
| Ecor1 Capital | 1,667,119 | $50M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Lakefront Biotherapeutics American Depositary Shares on SentiSense.